Valence ロゴ
人気
ログイン
Loading data for GRCE — first visit, this takes a few seconds.

ウォッチリストに追加

Grace Therapeutics Inc.

NasdaqCM: GRCE · リアルタイム株価 · USD
2.14
-0.06 (-2.73%)
終値時点： Aug 20, 2026, 2:55 PM

Grace Therapeutics Inc. (GRCE) Stock Price, Analysis & Data

-2.73%
買気配1.55
時価総額45.02M
売上高（TTM）n/a
純利益（TTM）-20.22M
ベータn/a
EPS（TTM）-1.17
PER（TTM）n/a
予想PER-4.65
PBR（TTM）0.72
PSR（TTM）n/a
Earnings DateJun 20, 2025
売気配2.86
出来高48,047
平均出来高（20日）255,427
始値2.19
前日終値2.20
当日レンジ2.10 - 2.24
52週レンジ1.79 - 5.18
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

GRCEについて

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-form...

[続きを読む]
業種 Biotechnology
セクター Healthcare
IPO日 Feb 7, 2012
従業員数 5
上場取引所 NasdaqCM
ティッカー GRCE
ウェブサイト https://www.gracetx.com
企業情報の全文

業績

2026年のGrace Therapeuticsの売上高は0で、前年の0からundefined%の増加でした。 利益は-7.79Mで、-18.55%の減少でした。

財務諸表

決算サプライズ

Grace TherapeuticsはAug 13, 2026に四半期決算を発表しました：
  • 売上高は $0 で、予想を下回りました $0, うち NaN% の前年比増加にあたります.
  • EPSは -0.18 で、予想を下回りました 0.00, うち 37.93% の前年比増加にあたります.

    • 次回決算発表

    Grace Therapeutics Inc.の決算発表予定日は Jun 20, 2025, 寄り付き前の予定です。
    アナリストの売上高予想は ... アップグレード
    news image

    3か月前 · MT Newswires

    Sector Update: Health Care Stocks Edge Lower Late Afternoon

    Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the Stat

    news image

    4か月前 · Simply Wall St.

    We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate

    Just because a business does not make any money, does not mean that the stock will go down. For example, Grace...

    news image

    9か月前 · Simply Wall St.

    This Grace Therapeutics Insider Increased Their Holding By 12% Last Year

    Insiders were net buyers of Grace Therapeutics, Inc.'s ( NASDAQ:GRCE ) stock during the past year. That is, insiders...

    news image

    11か月前 · Simply Wall St.

    We Think Grace Therapeutics (NASDAQ:GRCE) Needs To Drive Business Growth Carefully

    Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...